immunotherapy – Page 2

Dendritic Cell-Based Therapeutic Immunization Induces Th1/Th17 Responses and Reduces Fungal Burden in Experimental Sporotrichosis

mycolabadmin

Researchers developed a vaccine using special immune cells called dendritic cells loaded with proteins from the fungus that causes sporotrichosis. When vaccinated mice were later infected with the fungus, they showed stronger immune responses and had lower levels of the fungus in their bodies. This suggests that dendritic cell-based vaccines could be a promising new treatment approach for sporotrichosis, a serious fungal infection that is difficult to treat with current medicines, especially in people with weakened immune systems.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

Dr. John Perfect shares decades of experience treating fungal infections and developing antifungal medications. He discusses how treatments have evolved from highly toxic drugs to more effective options, but notes that fungal infections remain challenging, especially when patients develop resistance or have serious underlying diseases. He emphasizes the importance of combining drugs with immune therapies and shorter, more potent treatments rather than lengthy medication courses. Despite challenges, Dr. Perfect is optimistic about the future of medicine and encourages young scientists to pursue careers in this field.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

Dr. John Perfect, a leading infectious disease expert, discusses his 48-year career studying fungal infections, particularly cryptococcal meningitis. He reflects on the dramatic transformation of HIV/AIDS from a fatal disease to a manageable chronic condition and emphasizes that antifungal resistance is less concerning than the underlying diseases that complicate treatment. Perfect advocates for developing more potent antifungal drugs that work faster, and discusses promising approaches like molecular diagnostics and immune-based therapies to improve patient outcomes.

Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia

mycolabadmin

Researchers tested a mushroom-derived supplement called AHCC against chronic lymphocytic leukemia in laboratory and animal studies. AHCC killed leukemia cells directly and also reduced supportive cells in the tumor environment. When combined with antibody therapy, AHCC significantly improved outcomes in mouse models, suggesting it could be a promising addition to current leukemia treatments.

Recent Discoveries on Marine Organism Immunomodulatory Activities

mycolabadmin

Scientists are discovering that creatures from the ocean produce powerful substances that can help our immune system fight diseases like cancer and inflammation. These marine organisms—from tiny algae to sponges to fish—create natural compounds that can either boost or calm down our immune response depending on what we need. Several of these ocean-derived medicines are already approved for treating serious diseases, and many more are being tested in clinical trials. The ocean covers 70% of our planet and most of it remains unexplored, suggesting there are many more beneficial compounds waiting to be discovered.

Unraveling the Fungi–Cancer Connection

mycolabadmin

Fungi living in and around tumors play surprisingly important roles in cancer development and treatment response, yet they have been largely overlooked compared to bacteria. Different cancer types host specific fungal species that can promote tumor growth through immune suppression and toxin production. By better understanding and potentially targeting these tumor-associated fungi, researchers believe we could develop new combination treatments that enhance the effectiveness of existing cancer therapies.

Advances in Fungal Infection Research: From Novel Diagnostics to Innovative Therapeutics

mycolabadmin

This editorial discusses the growing challenge of fungal infections worldwide, which disproportionately affect people with weakened immune systems. New diagnostic tools using molecular testing can now quickly identify fungal infections, while researchers are developing novel treatments including repurposed drugs and immune-boosting therapies. The article emphasizes that coordinated efforts among doctors, scientists, and public health officials are essential to combat rising antifungal resistance and improve patient outcomes.

Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives

mycolabadmin

Gastric cancer is a serious disease that often becomes resistant to chemotherapy drugs, making treatment difficult. This review examines how natural products found in plants and herbs can help overcome this drug resistance. These natural compounds work through multiple mechanisms, including targeting cancer stem cells, boosting the immune system, and enhancing the effectiveness of standard chemotherapy treatments.

Research Topic: immunotherapy